1-(Pyridin-4-ylmethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine, >95%, 1g

2,5-Dimethoxy-4-formylbenzoic acid, 98%, 500mg

Natronlauge 20 %, reinst, 25 l, kunststoffverpackung.

2-(5-BROMOTHIOPHEN-2-YL)ACETIC ACID, 95.0%, 10g

3-Bromo-4-methyl-benzenesulfonyl chloride, 95.0%, 10g

tert-Butyl (2S)-2-[(1S)-1-hydroxyethyl]pyrrolidine-1-carboxylate, 97%, 5g

(S)-4-Benzyl-3-phenylpiperazin-2-one, 95%, 250mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-((2,6-dichlorobenzyl)oxy)phenyl)propanoic acid, 95%, 10g

6-Bromo-4-fluoro-2-methyl-2,3-dihydro-1h-inden-1-one, 97%, 500mg

4-[(1,3-benzothiazol-2-yl)methyl]aniline, 97%, 100mg

GC-Kapillarsäule ROTI®Cap-5, 50 m, 0.25 mm, 0.10 µm, unpolar, 1 Stück

1-amino-3-(hydroxymethyl)cyclobutane-1-carboxylic acid, 95.0%, 10g

4-BROMO-1-METHYL-5-PHENYL-1H-PYRAZOLE, 95.0%, 100mg